ABOS
Acumen Pharmaceuticals, Inc.—15-min delayed · EOD close3.10 +6.16% upas of 2026-09-02mkt cap $224M
Biological Products, (No Diagnostic Substances) · SIC 2836 · CIK 0001576885
Analyst ratings unavailable.
The analyst ratings connector is switched off for this deployment.
Consensus counts and a target price come from Alpha Vantage; named firm ratings come from Finnhub or FMP. Add a key and set ENABLE_RATINGS=1.